stella
beta
Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism — Stella
Recruiting
Back to Hypoparathyroidism trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Peking Union Medical College Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov